195 related articles for article (PubMed ID: 33662962)
1. Pretreatment Apparent Diffusion Coefficient Cannot Predict Histopathological Features and Response to Neoadjuvant Radiochemotherapy in Rectal Cancer: A Meta-Analysis.
Surov A; Pech M; Powerski M; Woidacki K; Wienke A
Dig Dis; 2022; 40(1):33-49. PubMed ID: 33662962
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer.
Surov A; Wienke A; Meyer HJ
Breast; 2020 Oct; 53():59-67. PubMed ID: 32652460
[TBL] [Abstract][Full Text] [Related]
3. Apparent diffusion coefficient cannot discriminate metastatic and non-metastatic lymph nodes in rectal cancer: a meta-analysis.
Surov A; Meyer HJ; Pech M; Powerski M; Omari J; Wienke A
Int J Colorectal Dis; 2021 Oct; 36(10):2189-2197. PubMed ID: 34184127
[TBL] [Abstract][Full Text] [Related]
4. Apparent Diffusion Coefficient Can Predict Therapy Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization.
Drewes R; Heinze C; Pech M; Powerski M; Woidacki K; Wienke A; Surov A; Omari J
Dig Dis; 2022; 40(5):596-606. PubMed ID: 34749359
[TBL] [Abstract][Full Text] [Related]
5. Apparent Diffusion Coefficient Can Predict Response to Chemotherapy of Liver Metastases in Colorectal Cancer.
Drewes R; Pech M; Powerski M; Omari J; Heinze C; Damm R; Wienke A; Surov A
Acad Radiol; 2021 Nov; 28 Suppl 1():S73-S80. PubMed ID: 33008734
[TBL] [Abstract][Full Text] [Related]
6. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
7. Can apparent diffusion coefficient (ADC) distinguish breast cancer from benign breast findings? A meta-analysis based on 13 847 lesions.
Surov A; Meyer HJ; Wienke A
BMC Cancer; 2019 Oct; 19(1):955. PubMed ID: 31615463
[TBL] [Abstract][Full Text] [Related]
8. Apparent Diffusion Coefficient for Distinguishing Between Malignant and Benign Lesions in the Head and Neck Region: A Systematic Review and Meta-Analysis.
Surov A; Meyer HJ; Wienke A
Front Oncol; 2019; 9():1362. PubMed ID: 31970081
[No Abstract] [Full Text] [Related]
9. MRI In rectal cancer: Correlations between MRI features and molecular markers Ki-67, HIF-1α, and VEGF.
Meng X; Li H; Kong L; Zhao X; Huang Z; Zhao H; Zhu W; Li X; Yu J; Xing L
J Magn Reson Imaging; 2016 Sep; 44(3):594-600. PubMed ID: 26919464
[TBL] [Abstract][Full Text] [Related]
10. Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.
Zhao M; Zhao L; Yang H; Duan Y; Li G
Radiat Oncol; 2021 Jan; 16(1):17. PubMed ID: 33472660
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
De Felice F; Magnante AL; Musio D; Ciolina M; De Cecco CN; Rengo M; Laghi A; Tombolini V
Eur J Surg Oncol; 2017 Jul; 43(7):1324-1329. PubMed ID: 28363512
[TBL] [Abstract][Full Text] [Related]
12. MRI-Based Apparent Diffusion Coefficient for Predicting Pathologic Response of Rectal Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis.
Amodeo S; Rosman AS; Desiato V; Hindman NM; Newman E; Berman R; Pachter HL; Melis M
AJR Am J Roentgenol; 2018 Nov; 211(5):W205-W216. PubMed ID: 30240291
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.
Cai G; Xu Y; Zhu J; Gu WL; Zhang S; Ma XJ; Cai SJ; Zhang Z
World J Gastroenterol; 2013 Sep; 19(33):5520-7. PubMed ID: 24023496
[TBL] [Abstract][Full Text] [Related]
14. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
[No Abstract] [Full Text] [Related]
15. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
16. Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI.
Bostel T; Dreher C; Wollschläger D; Mayer A; König F; Bickelhaupt S; Schlemmer HP; Huber PE; Sterzing F; Bäumer P; Debus J; Nicolay NH
Radiat Oncol; 2020 Jul; 15(1):171. PubMed ID: 32653003
[TBL] [Abstract][Full Text] [Related]
17. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer.
Elmi A; Hedgire SS; Covarrubias D; Abtahi SM; Hahn PF; Harisinghani M
Clin Radiol; 2013 Oct; 68(10):e524-31. PubMed ID: 23830776
[TBL] [Abstract][Full Text] [Related]
18. Apparent diffusion coefficient measurement covering complete tumor area better predicts rectal cancer response to neoadjuvant chemoradiotherapy.
Blažić I; Maksimović R; Gajić M; Šaranović Đ
Croat Med J; 2015 Oct; 56(5):460-9. PubMed ID: 26526883
[TBL] [Abstract][Full Text] [Related]
19. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging for determining response to neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis.
Bilreiro C; Andrade L; Marques RM; Matos C
Eur Radiol; 2024 May; 34(5):3238-3248. PubMed ID: 37907761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]